NCT05107232 OSV-IRM - Volunteer MRI Sequence Optimization
| NCT ID | NCT05107232 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rennes University Hospital |
| Condition | MRI |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2021-11-04 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2021-11-04 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Optimization of magnetic resonance imaging (MRI) protocols on healthy volunteers and voluntary patients. In MRI, a large number of technical parameters (sequence, parameters in sequence, antenna, reconstruction method, etc.) can be changed to optimize the diagnostic quality of the exam. Some optimizations can be performed on participants healthy volunteers, others need to be carried out on images pathological and acquired in voluntary patients.
Eligibility Criteria
Inclusion Criteria: * Criteria common to all participants: * Minor or major subject * Affiliated, himself or through his parents if he is a minor, to a a social security scheme * Having given their free, informed and written consent, and/or which the free, informed and written consent of the holder(s) parental authority has been obtained for minors Specific criteria for healthy volunteers: o No medical or surgical history related to the anatomical area(s) scanned Specific criteria for voluntary patients: o Indication for an MRI exam as part of its management Exclusion Criteria: * \- Contraindication to an MRI (pacemaker or pacemaker, neurostimulator, intra-orbital metal body, vascular clip ferromagnetic) * Pregnancy * Legal protection measure for adults in progress (safeguard of justice, guardianship, curatorship) or subject deprived of liberty
Contact & Investigator
Jean-Christophe FERRE, Pr
PRINCIPAL INVESTIGATOR
Rennes University Hospital
Frequently Asked Questions
Who can join the NCT05107232 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, studying MRI. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05107232 currently recruiting?
Yes, NCT05107232 is actively recruiting participants. Contact the research team at blandine.gautier@chu-rennes.fr for enrollment information.
Where is the NCT05107232 trial being conducted?
This trial is being conducted at Rennes, France.
Who is sponsoring the NCT05107232 clinical trial?
NCT05107232 is sponsored by Rennes University Hospital. The principal investigator is Jean-Christophe FERRE, Pr at Rennes University Hospital. The trial plans to enroll 600 participants.